See also this year's filing and all EDGAR filings for this company.
PDF Report 0001701108_2023_Spero_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001701108, Spero Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 113,570,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 368,000 |
| 3 | remainder_Assets | 10,864,000 |
| 4 | LiabilitiesCurrent | 21,649,000 |
| 5 | LiabilitiesNoncurrent | 4,957,000 |
| 6 | remainder_Liabilities | 22,262,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 36,483,000 |
| 9 | ResearchAndDevelopmentExpense | 47,593,000 |
| 10 | remainder_Expenses | 11,630,000 |
| 11 | remainder_Revenues | 53,509,000 |
| 12 | remainder_NetIncome | -4,218,000 |
| 13 | remainder_ComprehensiveNetIncome | 2,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 124,802,000 |
| 1 | Liabilities | 48,868,000 |
| 2 | Expenses | 95,706,000 |
| 3 | Revenues | 53,509,000 |
| 4 | StockholdersEquity | 75,934,000 |
| 5 | NetIncome | -46,415,000 |
| 6 | ComprehensiveNetIncome | -46,414,000 |
| 7 | BaseVar | 163,552,500 |
| 8 | EconomicCapitalRatio | 0.970 |
Edgar->Model Mapping
Feature Distribution
Change over Time
